Abstract:Background: Muscle atrophy can cause muscle dysfunction and weakness. Krüppel-like factor 13 (KLF13), a central regulator of cellular energy metabolism, is highly expressed in skeletal muscles and implicated in the pathogenesis of several diseases. This study investigated the role of KLF13 in muscle atrophy, which could be a novel therapeutic target. Methods: The effects of gene knockdown and pharmacological targeting of KLF13 on skeletal muscle atrophy were investigated using cell-based and animal models. Clofoctol, an antibiotic and KLF13 agonist, was also investigated as a candidate for repurposing. The mechanisms related to skeletal muscle atrophy were assessed by measuring the expression levels and activation statuses of key regulatory pathways and validated using gene knockdown and RNA sequencing. Results: In a dexamethasone-induced muscle atrophy mouse model, the KLF13 knockout group had decreased muscle strength (N) (1.77 ± 0.10 vs. 1.48 ± 0.16, P < 0.01), muscle weight (%) [gastrocnemius (Gas): 76.0 ± 5.69 vs. 60.7 ± 7.23, P < 0.001; tibialis anterior (TA): 75.8 ± 6.21 vs. 67.5 ± 5.01, P < 0.05], and exhaustive running distance (m) (495.5 ± 64.8 vs. 315.5 ± 60.9, P < 0.05) compared with the control group. KLF13 overexpression preserved muscle mass (Gas: 100 ± 6.38 vs. 120 ± 14.4, P < 0.01) and the exhaustive running distance (423.8 ± 59.04 vs. 530.2 ± 77.45, P < 0.05) in an in vivo diabetes-induced skeletal muscle atrophy model. Clofoctol treatment protected against dexamethasone-induced muscle atrophy. Myotubes treated with dexamethasone, an atrophy-inducing glucocorticoid, were aggravated by KLF13 knockout, but anti-atrophic effects were achieved by inducing KLF13 overexpression. We performed a transcriptome analysis and luciferase reporter assays to further explore this mechanism, finding that delta-like 4 (Dll4) was a novel target gene of KLF13. The KLF13 transcript repressed Dll4, inhibiting the Dll4-Notch2 axis and preventing muscle atrophy. Dexamethasone inhibited KLF13 expression by inhibiting myogenic differentiation 1 (i.e., MYOD1)-mediated KLF13 transcriptional activation and promoting F-Box and WD repeat domain containing 7 (i.e., FBXW7)-mediated KLF13 ubiquitination. Conclusions: This study sheds new light on the mechanisms underlying skeletal muscle atrophy and potential drug targets. KLF13 regulates muscle atrophy and is a potential therapeutic target. Clofoctol is an attractive compound for repurposing studies to treat skeletal muscle atrophy.

The transcriptional regulator KLF15 is necessary for myoblast differentiation and muscle regeneration by activating FKBP5

KLF15 Regulates Slow Myosin Heavy Chain Expression Through NFATc1 in C2C12 Myotubes

Lkb1 is indispensable for skeletal muscle development, regeneration, and satellite cell homeostasis.

KLF5 regulates chicken skeletal muscle atrophy via the canonical Wnt/β-catenin signaling pathway

Sox15 and Fhl3 transcriptionally coactivate Foxk1 and regulate myogenic progenitor cells.

Foxk1 Promotes Cell Proliferation and Represses Myogenic Differentiation by Regulating Foxo4 and Mef2.

KLF13 restrains Dll4-muscular Notch2 axis to improve the muscle atrophy

Uncovering the Transcriptional Circuitry in Skeletal Muscle Regeneration

KLF7 Regulates Satellite Cell Quiescence in Response to Extracellular Signaling.

Interleukin-15 facilitates muscle regeneration through modulation of fibro/adipogenic progenitors

Krüppel-like Factor 15: A Potential Therapeutic Target for Kidney Disease

KLF15 overexpression in myocytes fails to ameliorate ALS-related pathology or extend the lifespan of SOD1G93A mice

Identification of a KLF5-dependent program and drug development for skeletal muscle atrophy

Dlk1 is Necessary for Proper Skeletal Muscle Development and Regeneration

Inactivating IL34 promotes regenerating muscle stem cell expansion and attenuates Duchenne muscular dystrophy in mouse models

KLF5 Functions in Proliferation, Differentiation, and Apoptosis of Chicken Satellite Cells

Myofiber Baf60c controls muscle regeneration by modulating Dkk3-mediated paracrine signaling

Effects of Kruppel-Like Factor 15 on Fat Deposition and Muscle Fiber Types and Its Possible Mechanism

LncRNA 4930581F22Rik promotes myogenic differentiation by regulating the ERK/MAPK signaling pathway

Myogenic Regulatory Factors Transactivate the Tceal7 Gene and Modulate Muscle Differentiation.

Fhl2 interacts with Foxk1 and corepresses Foxo4 activity in myogenic progenitors.